WEBINAR ON DEMAND
Duration: 60 minutes

GLP-1s have completely reshaped how we approach and treat obesity, yet challenges remain for employers and employees alike. The majority of employers are still concerned about the short- and long-term cost implications of GLP-1s. Even when GLP-1s are covered, members are struggling to access the medications amid a prolonged global shortage. So where do we go from here? 

In this webinar, Dr. Linda Anegawa, Chief of Medicine at Noom and dual-board certified physician in Internal Medicine and Obesity Medicine, and Jordan Galante, Director of National Accounts at Noom, will dive into the future of GLP-1s. Join us and you’ll learn:

• GLP-1 trends going into 2024
• How those trends could influence your health and benefits strategy
• Ways to get ahead of the GLP-1 cost and supply-demand curves

SPEAKERS

Dr. Linda Anegawa
Chief of Medicine
Noom

Jordan Galante
Director of National Accounts
Noom